Brain microstructure abnormalities in the 3xTg-AD mouse – A diffusion MRI and morphology correlation study
Open accessAbstract
The widely studied triple transgenic (3xTg-AD) mouse provides a robust model of Alzheimer's disease (AD) with region dependent patterns of progressive amyloid-β (Aß) and tau pathology. Using diffusion MRI (dMRI), we investigated the sensitivity of dMRI measures in capturing AD pathology associated microstructure alterations in older 3xTg-AD mice, and the degree to which dMRI changes correlate with measurements of Aβ and tau pathology. 3xTg-AD and normal control (NC) mice, 15 to 21 months of age, were used in this study. In vivo dMRI data were acquired for the generation of diffusion tensor (DT) and diffusional kurtosis (DK) measures within the hippocampus and fimbria (Fi). For these same brain regions, Aβ and tau pathology were quantified by morphological analysis of Aß1-42 and AT8 immunoreactivity. Two-tailed, two-sample t-tests were performed to assess group differences in each brain region of interest (ROI), with the Benjamini-Hochberg false discovery rate (FDR) method being applied to adjust for multiple comparisons. Spearman correlation coefficients were calculated to investigate associations between diffusion and morphological measures. Our results revealed, depending on the brain region, DT and DK measures were able to detect group differences. In the dorsal hippocampus (HD), fractional anisotropy (FA) was significantly higher in the 3xTg-AD mice compared with NC mice. In the subiculum (SUB), FA, axial diffusivity (D||) and radial kurtosis (K┴) were significantly higher in 3xTg-AD mice compared with NC mice. Morphological quantification of Aß1-42 and AT8 immunoreactivity showed elevated Aß and tau in the Fi, ventral hippocampus (HV) and SUB of 3xTg-AD mice. The presence of Aβ and tau was significantly correlated with several DT and DK measures, particularly in the SUB, where an increase in tau correlated with an increase in mean kurtosis (MK) and K┴. This work demonstrates significant dMRI differences between older 3xTg-AD and NC mice in the hippocampus and Fi. Significant correlations were found between dMRI and morphological measures of Aβ and tau pathology. These results support the potential of dMRI-derived parameters as biomarkers of AD pathology. Since the imaging methods employed here are easily translatable to clinical MRI, our results are also relevant for human AD patients.
AI snapshot
Written from the paper’s full text.
TL;DR
In older 3xTg-AD mice, diffusion MRI detected region-dependent microstructural differences in the hippocampus and fimbria that correlated with Aβ and tau pathology. The results support dMRI-derived parameters as potential translatable biomarkers of AD pathology.
Key findings
- In the dorsal hippocampus (HD), fractional anisotropy (FA) was significantly higher in 3xTg-AD mice than normal controls; higher axial diffusivity (D∥) showed a trend that did not survive FDR correction.
- In the subiculum (SUB), FA, D∥, and radial kurtosis (K⊥) were significantly higher in 3xTg-AD mice; trends for higher FA in ventral hippocampus (HV), K∥ in fimbria (Fi), and KFA in SUB did not remain significant after FDR adjustment.
- Morphological quantification showed significantly increased Aβ1-42 and AT8 immunoreactivity in the Fi, HV, and SUB of 3xTg-AD mice; in HD, only Aβ was significantly increased.
- Aβ and tau presence correlated significantly with several diffusion tensor and diffusional kurtosis metrics, particularly in SUB, where increased tau correlated with increased mean kurtosis (MK) and K⊥.
Methods
- Thirteen 3xTg-AD and eleven normal control female mice were imaged at 15, 18, and 21 months of age; in vivo dMRI was performed on a 7T Bruker scanner using a 2-shot SE-EPI DKI sequence with 30 diffusion-encoding directions and four b-values (0.5, 1.0, 1.5, and 2.0 ms/μm²).
- ROIs were manually drawn for dorsal hippocampus, ventral hippocampus, subiculum, and fimbria; DTI and DKI metrics were calculated after motion correction, denoising, and tensor fitting.
- After MRI, brains were stained for Aβ1-42 and AT8, immunoreactivity was quantified as optical density in matched ROIs, and analyses used two-tailed two-sample t-tests with Benjamini-Hochberg FDR correction for DT and DK metrics, Cohen’s d, and Spearman correlations between diffusion and morphology measures.
Limitations
- The authors state that the relatively small total number of mice, especially at later ages, reduced statistical power; mice from all time points and both groups were pooled for Spearman correlations, and age-dependent changes were not assessed.
- The authors also state that large ROIs for HD and HV may have attenuated some effects due to variability in AD pathology, and that imaging resolution was insufficient to confidently discriminate CA1 and CA3 regions.
- Evident from the text: only female mice were used, so findings may not generalize to male 3xTg-AD mice; Spearman correlations were not adjusted for multiple comparisons.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
25 of 38 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured
- Premisecitation
The authors demonstrated that dMRI measures capture the larger number of cholinergic neurons in the basal forebrain of young 3xTg-AD mice.
“Additionally, we demonstrated that dMRI measures are able to capture the larger number of cholinergic neurons reported in the BF of these young 3xTg-AD mice [16].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [16] Falangola MF, Nie X, Ward R, Dhiman S, Voltin J, Nietert PJ, Diffusion MRI detects basal forebrain cholinergic abnormalities in the 3xTg-AD mouse model of Alzheimer’s disease. Magn Reson Imaging 2021; 83: 1– 13. 34229088 PMC8449815 source
The Discussion (page not provided) reports significant basal-forebrain dMRI differences in two-month-old 3xTg-AD mice and says these may be related to an increased number of cholinergic neurons. It also says the study lacks a direct correlation with morphological data, so it does not demonstrate that dMRI measures capture the larger neuron number specifically. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
The 3xTg-AD mouse provides a robust model of Alzheimer's disease with region-dependent patterns of progressive amyloid-β and tau pathology.
“The widely studied triple transgenic (3xTg-AD) mouse provides a robust model of Alzheimer’s disease (AD) with region dependent patterns of progressive amyloid-β (Aß) and tau pathology.”
- Also stated in: § Discussion · plain
“The 3xTg-AD mouse used in the current study provides a robust model of progressive region dependent Aß and tau pathology, with evident and sustained accumulation of plaques and tangles after 12 months of age [5, 6, 28].”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [5] Oh KJ, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ. Staging of Alzheimer’s pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis 2010; 2010: 780102. 20798886 PMC2925282 source
- cites [6] Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Temporal and regional progression of Alzheimer’s disease-like pathology in 3xTg-AD mice. Aging Cell 2019; 18(1): e12873. 30488653 PMC6351836 source
The Results sections on plaques and tau pathology document age-dependent, region-specific progression, and the Discussion describes a consistent, predictable phenotype in female 3xTg-AD mice. The claim leaves that qualification out: the Animals section says only females were analyzed because males in this colony showed substantial neuropathological variability, and the Introduction notes differences among sublines. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [28] Javonillo DI, Tran KM, Phan J, Hingco E, Kramár EA, da Cunha C, Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease. Frontiers in Neuroscience 2022; 15. PMC8818877 35140584 source
- Also stated in: § Discussion · plain
- Premisecitation
Previously, the authors showed that dMRI detects early myelin abnormalities in the hippocampus, fimbria and fornix of 2-month-old 3xTg-AD mice.
“Previously, we have shown that dMRI is able to detect the early myelin abnormalities described in this AD mouse, particularly in the hippocampus, fimbria and fornix of 2-month-old 3xTg-AD mice [15].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] Falangola MF, Nie X, Ward R, McKinnon ET, Dhiman S, Nietert PJ, Diffusion MRI detects early brain microstructure abnormalities in 2-month-old 3xTg-AD mice. NMR Biomed 2020; 33(9): e4346. 32557874 PMC7683375 source
The Abstract reports dMRI differences in the hippocampus, fimbria and fornix of 2-month-old 3xTg-AD mice and associates them with myelin abnormalities. The Discussion reports a myelin measurement in the fimbria but says further work is needed to establish a direct correlation between dMRI and morphological findings; it does not establish that dMRI specifically detected myelin abnormalities in all three regions. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
The authors found that dMRI metrics change longitudinally with aging and AD pathology progression in several brain regions.
“Moreover, we found that dMRI metrics change longitudinally with aging [16] and AD pathology progression [17] in several brain regions.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [16] Falangola MF, Nie X, Ward R, Dhiman S, Voltin J, Nietert PJ, Diffusion MRI detects basal forebrain cholinergic abnormalities in the 3xTg-AD mouse model of Alzheimer’s disease. Magn Reson Imaging 2021; 83: 1– 13. 34229088 PMC8449815 source
- cites [17] Nie X, Falangola MF, Ward R, McKinnon ET, Helpern JA, Nietert PJ, Diffusion MRI detects longitudinal white matter changes in the 3xTg-AD mouse model of Alzheimer’s disease. Magn Reson Imaging 2019; 57: 235– 42. 30543850 PMC6331227 source
The Results report longitudinal changes in dMRI measures across several white-matter regions of 3xTg-AD mice. The Discussion suggests that some changes accompany AD-like pathology progression, but says the absence of a control group prevents separating pathology-related changes from aging; it does not establish that progression caused the measured changes. Page numbers were not provided. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
The 3xTg-AD mouse develops both amyloid-β and neurofibrillary tangles in a temporal and spatial pattern similar to human AD pathology.
“It develops both amyloid-β (Aβ) and neurofibrillary tangles in a temporal and spatial pattern similar to human AD pathology [3–6].”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [3] Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiol Aging 2003; 24(8): 1063– 70. 14643377 source
- cites [4] Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 2006; 281(3): 1599– 604. 16282321 source
- cites [5] Oh KJ, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ. Staging of Alzheimer’s pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis 2010; 2010: 780102. 20798886 PMC2925282 source
The Introduction and Discussion describe age-related amyloid and tau pathology across brain regions, and the Discussion compares plaque and tangle-bearing neuron morphology with human AD. The paper does not establish that the overall temporal and spatial pattern of both pathologies matches human AD; it also notes differences in tau pathology. Page numbers were not available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [6] Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Temporal and regional progression of Alzheimer’s disease-like pathology in 3xTg-AD mice. Aging Cell 2019; 18(1): e12873. 30488653 PMC6351836 source
- Study design and conductcitation
Due to the variability of the degree of AD pathology described in this model, large ROIs, as used for the HD and HV, may have attenuated some effects.
“Additionally, due to the variability of the degree of AD pathology described in this model [4, 6, 26], large ROIs, as used for the HD and HV, may have attenuated some effects.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [4] Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 2006; 281(3): 1599– 604. 16282321 source
The section on age-dependent oligomer accumulation describes changes in pathology with age and within the CA1/subiculum, but does not report variability in the degree of AD pathology among mice in this model. Searches for variability, differences among animals, and regional heterogeneity found no passage establishing the premise attributed to this source. The suggestion that large ROIs attenuated effects is the citing authors’ own inference. (LLM, conf=0.70)
Experimental — accuracy not yet measured - cites [6] Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Temporal and regional progression of Alzheimer’s disease-like pathology in 3xTg-AD mice. Aging Cell 2019; 18(1): e12873. 30488653 PMC6351836 source
- cites [26] Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. Compact 2nd ed. Amsterdam; Boston: Elsevier Academic Press; 2004.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The increase of FA and KFA in the hippocampus may be related to the progressive loss of cholinergic unmyelinated axons, resulting in a more aligned, anisotropic environment.
“The increase of FA and KFA in the hippocampus may be related to the progressive loss of cholinergic unmyelinated axons [9], resulting in a more aligned, anisotropic environment.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [9] Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD, Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis 2011; 41(2): 338– 52. 20937383 PMC3014453 source
The Results section reports a qualitative decrease in cholinergic fiber staining in the subiculum of aged female 3xTg-AD mice, less obvious in the hippocampus proper. The Discussion says the study did not count fibers; it cites other studies for age-dependent fiber loss. Thus, this paper supports cholinergic fiber alteration but does not establish progressive loss of unmyelinated hippocampal axons. The FA/KFA explanation is the citing authors’ proposed interpretation, not a finding attributed to this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data
In the subiculum (SUB), FA, axial diffusivity (D∥) and radial kurtosis (K⊥) were significantly higher in 3xTg-AD mice compared with normal control mice.
“In the SUB, FA, D∥ and K⊥ are significantly higher in the TG mice compared with NC mice.”
Quote in the paperSubstantial claim - Findingown data
The dMRI results reveal group differences between older 3xTg-AD and normal control mice in brain regions having AD pathology, particularly in the dorsal hippocampus (HD) and subiculum (SUB).
“Our dMRI results reveal group differences between older TG and NC mice in brain regions having AD pathology, particularly in the HD and SUB.”
Quote in the paperSubstantial claim - Findingown data
The presence of Aβ and tau was significantly correlated with several dMRI metrics.
“The presence of Aβ and tau was significantly correlated with several dMRI metrics, as seen in Figure 4 (unadjusted p values), which shows the correlations that were statistically significant (in bold) or had a trend to be correlated in each region.”
- Also stated in: § Abstract · plain
“The presence of Aβ and tau was significantly correlated with several DT and DK measures, particularly in the SUB, where an increase in tau correlated with an increase in mean kurtosis (MK) and K⊥.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
In the dorsal hippocampus (HD), fractional anisotropy (FA) was significantly higher in 3xTg-AD mice compared with normal control mice.
“In the dorsal hippocampus (HD), fractional anisotropy (FA) was significantly higher in the 3xTg-AD mice compared with NC mice.”
- Also stated in: § Results · plain
“As shown in Table1, in the HD, FA values are significantly higher in the TG mice compared with NC mice”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data
In the dorsal hippocampus (HD), only Aβ was significantly increased in 3xTg-AD mice compared with controls.
“In the HD only Aß was significantly increased in the TG mice compared with controls.”
Quote in the paperNot a substantial claim - Findingown data
Morphological quantification of Aβ1-42 and AT8 immunoreactivity showed statistically significant increases of Aβ and tau in the fimbria (Fi), ventral hippocampus (HV) and subiculum (SUB) of 3xTg-AD mice compared with controls.
“Morphological quantification of Aß1-42 and AT8 immunoreactivity showed elevated Aß and tau in the Fi, ventral hippocampus (HV) and SUB of 3xTg-AD mice.”
- Also stated in: § Results · plain
“Morphological quantification of Aß1-42 and AT8 immunoreactivity, as seen in Figure 3, shows statistically significant group differences, with increases of Aß and tau in the Fi, HV and SUB of TG mice.”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data
In the hippocampus, the presence of Aβ plaques in the ventral hippocampus (HV) leads to an increase in kurtosis fractional anisotropy (KFA).
“In the hippocampus, the presence of tau pathology in the HD leads to an increase of K∥, and the presence of Aβ plaques in the HV leads to an increase of KFA.”
Quote in the paperSubstantial claim - Findingown data
In the subiculum (SUB), the accumulation of phosphorylated tau correlates with an increase in FA, D∥, MK and K⊥.
“In the SUB, the presence of Aβ plaques correlates with an increase in K⊥, and the accumulation of phosphorylated tau correlates with an increase in FA, D∥, MK and K⊥.”
Quote in the paperSubstantial claim - Findingown data
In the fimbria (Fi), the presence of intracellular tau pathology correlates with an increase in axial kurtosis (K∥).
“As seen in Figure 4, extracellular Aβ plaques in the Fi correlates with a decrease in D∥ and an increase K∥, while the presence of the intracellular tau pathology correlates with an increase K∥.”
Quote in the paperSubstantial claim - Findingown data
In the hippocampus, the presence of tau pathology in the dorsal hippocampus (HD) leads to an increase in axial kurtosis (K∥).
“In the hippocampus, the presence of tau pathology in the HD leads to an increase of K∥, and the presence of Aβ plaques in the HV leads to an increase of KFA.”
Quote in the paperSubstantial claim - Findingown data
In the subiculum (SUB), the presence of Aβ plaques correlates with an increase in radial kurtosis (K⊥).
“In the SUB, the presence of Aβ plaques correlates with an increase in K⊥, and the accumulation of phosphorylated tau correlates with an increase in FA, D∥, MK and K⊥.”
Quote in the paperSubstantial claim - Findingown data
In the subiculum (SUB), an increase in tau correlated with an increase in mean kurtosis (MK) and radial kurtosis (K⊥).
“The presence of Aβ and tau was significantly correlated with several DT and DK measures, particularly in the SUB, where an increase in tau correlated with an increase in mean kurtosis (MK) and K⊥.”
Quote in the paperSubstantial claim - Premisecitation
The 3xTg-AD mouse possesses three mutations in homologous mouse genes associated with human familial Alzheimer's disease (APP Swedish, MAPT P301L, and PSEN1 M146V).
“This model possesses three mutations in homologous mouse genes associated with human familial Alzheimer’s disease (APP Swedish, MAPT P301L, and PSEN1 M146V) [2].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003; 39(3): 409– 21. 12895417 source
- Premisenone given
The morphological correlation between AD pathology and the dMRI changes reported for this AD mouse model had not yet been established.
“However, we have not yet established the morphological correlation between the AD pathology and the dMRI changes we reported for this AD mouse model.”
Quote in the paperSubstantial claim - Study design and conductown data
The imaging resolution is not sufficient to discriminate with confidence the CA1 and CA3 regions as needed for a more refined comparison with morphology.
“This is an inherent methodological limitation of our dMRI data acquisition since the imaging resolution is not sufficient to discriminate with confidence the CA1 and CA3 regions as needed for a more refined comparison with morphology.”
Quote in the paperNot a substantial claim - Study design and conductown data
The relatively small total number of mice, particularly at latter ages, reduced the statistical power of the data analysis.
“One important limitation of our study is the relatively small total number of mice, particularly those at latter ages, which reduced the statistical power of the data analysis.”
Quote in the paperNot a substantial claim - Interpretationown data
The dMRI metrics are associated with pathology-induced brain microstructure alterations and group differences, even with the relatively small number of mice in each group.
“Our results show that dMRI metrics are associated with pathology induced brain microstructure alterations and group differences, even with the relatively small number of mice in each group.”
Quote in the paperSubstantial claim - Interpretationown data
The dMRI differences reflect changes in the diffusion environment associated with the presence of Aβ aggregates and phosphorylated tau.
“These differences reflect changes in the diffusion environment associated with the presence of Aβ aggregates and phosphorylated tau.”
Quote in the paperSubstantial claim - Premisecitation
The authors' dMRI results are generally consistent with those reported using other mouse models of AD.
“Our dMRI results are generally consistent with those reported using other mouse models of AD [31–35].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [31] Song SK, Kim JH, Lin SJ, Brendza RP, Holtzman DM. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol Dis 2004; 15(3): 640– 7. 15056472 source
- cites [32] Sun SW, Song SK, Harms MP, Lin SJ, Holtzman DM, Merchant KM, Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer’s disease using magnetic resonance diffusion tensor imaging. Exp Neurol 2005; 191(1): 77– 85. 15589514 source
- cites [33] Zerbi V, Kleinnijenhuis M, Fang X, Jansen D, Veltien A, Van Asten J, Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model. Neurobiol Aging 2013; 34(5): 1440– 50. 23273575 source
- cites [34] Qin YY, Li MW, Zhang S, Zhang Y, Zhao LY, Lei H, In vivo quantitative whole-brain diffusion tensor imaging analysis of APP/PS1 transgenic mice using voxel-based and atlas-based methods. Neuroradiology 2013; 55(8): 1027– 38. 23644540 source
- cites [35] Shu X, Qin YY, Zhang S, Jiang JJ, Zhang Y, Zhao LY, Voxel-based diffusion tensor imaging of an APP/PS1 mouse model of Alzheimer’s disease. Mol Neurobiol 2013; 48(1): 78– 83. 23877934 source
- Interpretationown data
The results support the potential of dMRI parameters as biomarkers of AD pathology.
“Therefore, our results support the potential of dMRI parameters as biomarkers of AD pathology.”
- Also stated in: § Abstract · plain
“These results support the potential of dMRI-derived parameters as biomarkers of AD pathology.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Interpretationreasoning
The 3xTg-AD mouse model is well-suited to investigate the potential relationships between AD pathological features and dMRI measurements.
“Therefore, this model is well-suited to investigate the potential relationships between AD pathological features and dMRI measurements.”
Quote in the paperSubstantial claim
- May combine two claims. 14
- Classified as probably not a substantial claim. 10
May combine two claims.
PremisecitationOnly female mice were used because AD pathology development is far less pronounced and more variable in male 3xTg-AD mice.
“Only female mice were used in this study since the development of AD pathology is far less pronounced and more variable in male 3xTg-AD mice [18,19].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [18] Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008; 1216: 92– 103. 18486110 source
- cites [19] Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ. Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res. 2010; 1366: 233– 45. 20934413 PMC2993873 source
The Results section ('Female 3xTg-AD mice display higher levels of Aβ immunoreactivity than males'; page unavailable) reports greater Aβ loads and more plaques in females than in age-matched males. This supports less pronounced amyloid pathology in males, but the paper does not establish that pathology development in males is more variable. 'Only female mice were used' describes the citing study, not this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe Benjamini-Hochberg false discovery rate method was used to adjust for multiple testing of DT and DK parameters within each ROI.
“The Benjamini-Hochberg false discovery rate (FDR) method [25] was used to adjust for multiple testing of DT (N = 4) and DK (N = 4) parameters within each ROI.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [25] Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9(7): 671– 5. 22930834 PMC5554542 source
The cited paper’s ‘Integration with other tools’ section discusses ImageJ and mentions exporting data for statistical analysis, but does not describe the Benjamini–Hochberg method or adjustments within ROIs. Searches for false discovery rate and for DT/DK parameters found no passage addressing the claim; page numbers were not available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn 3xTg-AD mice, both Aβ and tau exhibit age- and region-dependent formation, with Aβ plaques appearing prior to tangles, which are extensive in older transgenic mice.
“Both Aβ and tau exhibit age- and region-dependent formation in these mice, with Aβ plaques appearing prior to tangles, which are extensive in older transgenic mice.”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [3] Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiol Aging 2003; 24(8): 1063– 70. 14643377 source
- cites [4] Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 2006; 281(3): 1599– 604. 16282321 source
The Results section (page unavailable) describes age-dependent Aβ accumulation in the hippocampus and reports early tau pathology at 6 months and advanced tangles at 20 months. It does not establish that plaques appear before tangles or that both Aβ and tau formation are region-dependent; its explicit timing comparison is between Aβ oligomers and plaques. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [5] Oh KJ, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ. Staging of Alzheimer’s pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis 2010; 2010: 780102. 20798886 PMC2925282 source
The Discussion (page unavailable) reports that Aβ plaques increase with age and that tau pathology varies by age and brain region. Plaques were observed before filamentous tau aggregates, but the paper does not establish that tangles are extensive in older mice; its Discussion reports straight tau filaments in aged mice. It also distinguishes these late filaments from tau immunoreactivity present before plaque deposition. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [6] Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Temporal and regional progression of Alzheimer’s disease-like pathology in 3xTg-AD mice. Aging Cell 2019; 18(1): e12873. 30488653 PMC6351836 source
The Results sections on plaque accumulation and tau pathology (page unavailable) show age- and region-dependent changes in female 3xTg-AD mice: plaques first appear in the hippocampus at 6 months, and phosphorylated-tau immunoreactivity becomes extensive there at 12 and 20 months. The paper measures phosphorylated tau, not the formation or extent of tangles, so it does not establish that plaques appeared before tangles or that tangles were extensive in older mice. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
FindingcitationAβ plaque and tau pathology are evident in 15-month-old TG mice, and significantly increased with age.
“In our morphological analysis (Fig. 2 and 3), as previously described [3–6, 28], Aβ plaque and tau pathology are evident in 15-month-old TG mice, and significantly increased with age (online supplementary Fig.1 and 2).”
Quote in the paperSubstantial claim4 of 5 sources checked- cites [3] Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiol Aging 2003; 24(8): 1063– 70. 14643377 source
- cites [4] Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 2006; 281(3): 1599– 604. 16282321 source
The Results section (page unavailable) describes age-related Aβ accumulation in 3xTg-AD mice and tau pathology that is apparent by 6 months and advanced by 20 months. It does not specifically assess 15-month-old mice or establish a statistically significant age-related increase in both plaques and tau pathology; the citing sentence points to its own figures for that finding. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [5] Oh KJ, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ. Staging of Alzheimer’s pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis 2010; 2010: 780102. 20798886 PMC2925282 source
The Results (3.1 and 3.3; page unavailable) describe age-related increases in immunoreactivity and tau markers, and the Discussion (section 4; page unavailable) says Aβ plaque numbers increased with age. But this study did not examine 15-month-old mice—it sampled 8–9 and 18–20 months instead—and these passages do not establish a statistically significant increase in both plaque and tau pathology. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [6] Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Temporal and regional progression of Alzheimer’s disease-like pathology in 3xTg-AD mice. Aging Cell 2019; 18(1): e12873. 30488653 PMC6351836 source
The Results sections on plaque accumulation and tau pathology report both pathologies in 12- and 20-month-old 3xTg-AD mice, with significant age-dependent increases in immunoreactivity. The paper studied 2-, 6-, 12-, and 20-month-old mice, not 15-month-old mice, so it does not directly establish the claim at that age. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [28] Javonillo DI, Tran KM, Phan J, Hingco E, Kramár EA, da Cunha C, Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease. Frontiers in Neuroscience 2022; 15. PMC8818877 35140584 source
The Results sections on fibrillar Aβ plaques and phosphorylated tau report age-related increases in 3xTg-AD mice. However, the paper examines mice at 4, 12, and 18 months—not 15 months—and says plaque accumulation is largely driven by females, so it does not establish the claim at the stated age for TG mice generally. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAt 15 months, intense pathology is present in the TG mice, including Aβ plaques, tau, myelin damage, axonal degeneration, axonal loss, and an inflammatory reaction with reactive microglia and astrocytes.
“At 15 months, intense pathology is present in the TG mice, which includes not only Aβ plaques and tau, but also confounding factors, such as, myelin damage, axonal degeneration, axonal loss, and an inflammatory reaction with reactive microglia and astrocytes [29, 30].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [29] Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer’s disease syndrome. Alzheimer’s Res Ther 2013; 5(1): 1. 23302773 PMC3580331 source
The Disease topography section discusses plaques and tau-related pathology in human Alzheimer’s disease, while the white matter hyperintensities section discusses human imaging findings. Searches for 15-month-old TG mice, myelin and axonal damage, and reactive microglia and astrocytes found no passage addressing the claimed mouse pathology. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [30] Dá Mesquita S, Ferreira AC, Sousa JC, Correia-Neves M, Sousa N, Marques F. Insights on the pathophysiology of Alzheimer’s disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. Neurosci Biobehav Rev 2016; 68: 547– 62. 27328788 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNon-Gaussian diffusion is typically a consequence of barriers and compartments, and higher kurtosis values imply greater diffusional heterogeneity.
“Non-Gaussian diffusion is typically a consequence of barriers and compartments, and higher kurtosis values imply greater diffusional heterogeneity [12–14].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [12] Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005; 53(6): 1432– 40. 15906300 source
The Special Cases section says kurtosis reflects diffusional heterogeneity in a compartment model and tends to increase with heterogeneity; it also says diffusion barriers and water exchange can alter kurtosis. The claim overstates this qualified relationship by implying that a higher kurtosis value necessarily means greater heterogeneity. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [13] Lu H, Jensen JH, Ramani A, Helpern JA. Three-dimensional characterization of non-gaussian water diffusion in humans using diffusion kurtosis imaging. NMR Biomed 2006; 19(2): 236– 47. 16521095 source
- cites [14] Jensen JH, Helpern JA. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 2010; 23(7): 698– 710. 20632416 PMC2997680 source
May combine two claims.
Findingown dataThe increase of FA in the HD and SUB, and the increase of K⊥ in the SUB, were the best differentiators between the two groups in these regions.
“As seen in Table 1, the increase of FA in the HD and SUB, and the increase K⊥ in the SUB of TG mice were the best differentiators between the two groups in these regions.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the fimbria (Fi), extracellular Aβ plaques correlate with a decrease in axial diffusivity (D∥) and an increase in axial kurtosis (K∥).
“As seen in Figure 4, extracellular Aβ plaques in the Fi correlates with a decrease in D∥ and an increase K∥, while the presence of the intracellular tau pathology correlates with an increase K∥.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAβ1-42 and AT8 immunoreactivity was not present in normal control mice, although values for the NC group did not reach zero due to residual background stain.
“We note that values for the NC group does not reach zero due to residual background stain, but as expected and shown in Figure 2, Aß1-42 and AT8 immunoreactivity was not present in NC mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe authors have demonstrated significant dMRI differences in older 3xTg-AD compared with normal control mice, which were significantly correlated with Aβ and tau pathology in the hippocampus and fimbria.
“In summary, we have demonstrated significant dMRI differences in older 3xTg-AD, in comparison to NC mice, which were significantly correlated with Aβ and tau pathology in the hippocampus and Fi of the 3xTg-AD group.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenTo avoid bias in the ROIs, all mouse identification numbers were randomly assigned, and the number of MRI slices sampled was consistent across mice.
“To avoid bias in the ROIs, all the mice identification numbers were randomly assigned, and the number of MRI slices sampled was consistent across mice.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenImages were acquired under the same image light and camera settings to avoid possible image intensity variation.
“Images (4x magnification) were acquired under the same image light and camera settings to avoid possible image intensity variation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIntracellular tau causes axonal clogging, leading to axonal diffusion restriction, but ultimately tau pathology results in neuronal degeneration and increase in diffusivity.
“Intracellular tau causes axonal clogging, leading to axonal diffusion restriction, but ultimately tau pathology results in neuronal degeneration and increase in diffusivity.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataDue to the small number of mice at each time point, mice from all time points and from both groups were pooled for statistical analysis, and age-dependent changes were not assessed.
“Due to the small number of mice at each time point, mice from all time points and from both groups, were pooled for statistical analysis, and age dependent changes were not assessed.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSince the imaging methods employed here are easily translatable to clinical MRI, the results of this study are also relevant to human AD.
“Since the imaging methods employed here are easily translatable to clinical MRI, the results of this study are also relevant to human AD.”
- Also stated in: § Abstract · plain
“Since the imaging methods employed here are easily translatable to clinical MRI, our results are also relevant for human AD patients.”
Quote in the paperNot a substantial claim- Rests on an assumption: The imaging methods employed in this study are easily translatable to clinical MRI.
- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningSeveral biological processes may contribute to the dMRI changes reported here.
“Therefore, several biological processes may contribute to the dMRI changes reported here.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThe elevated kurtosis values found by the authors and other studies are not surprising.
“The elevated kurtosis values found by us and other studies are thus not surprising.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataExtracellular Aβ aggregates change the geometry of the extracellular space, creating more barriers, increasing tissue heterogeneity, and leading to restriction of the diffusion environment.
“Extracellular Aβ aggregates changes the geometry of the extracellular space, creating more barriers, increasing the tissue heterogeneity, and leading to restriction of the diffusion environment.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenOther microstructural changes associated with AD pathology, such as neurodegeneration, may tend to lower the kurtosis.
“Nonetheless, it should be noted that other microstructural changes associated with AD pathology, such as neurodegeneration, may tend to lower the kurtosis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNo adjustment for multiple comparison corrections was done for the Spearman correlations between dMRI metrics and morphology measures.
“Spearman correlation coefficients were calculated between the dMRI metrics and the morphology measures; no adjustment for multiple comparison corrections was done.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The imaging methods employed in this study are easily translatable to clinical MRI.
“Since the imaging methods employed here are easily translatable to clinical MRI, the results of this study are also relevant to human AD.”
“Since the imaging methods employed here are easily translatable to clinical MRI, our results are also relevant for human AD patients.”
The paper relies on this without support.
Pooling mice from all time points and both groups does not confound the observed correlations between dMRI metrics and Aβ/tau pathology.
“Due to the small number of mice at each time point, mice from all time points and from both groups, were pooled for statistical analysis, and age dependent changes were not assessed.”
The paper relies on this without support.
The post-mortem morphological measurements reflect the same pathological state present during the in vivo dMRI acquisition.
“Following the MRI scan, mice were sacrificed for morphological analysis of the degree of Aβ and tau pathology.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Myelin damage in the left dentate gyrus and right sAMY may represent key features of pathological transformation at this stage.
“At this particular stage, myelin damage in the left dentate gyrus and right sAMY may represent key features of pathological transformation.”
From Multimodal MRI combined with RNA sequencing reveals pathological signatures in the 9-month-old 3×Tg-AD mouse brain (2026) · cites this paper as Falangola et al., 2022
The Discussion (page unavailable) identifies myelin damage as one possible component of pathology in 15-month-old 3xTg-AD mice. It does not identify damage in the left dentate gyrus or right sAMY, or describe damage in those regions as key to pathological transformation. (LLM, conf=0.85)
Experimental — accuracy not yet measuredThe reduced integrity observed at this stage may reflect specific pathology patterns characterized by extensive intracellular Aβ aggregates and emerging extracellular Aβ and tau immunoreactivity.
“The reduced integrity observed at this stage may reflect specific pathology patterns characterized by extensive intracellular Aβ aggregates and emerging extracellular Aβ and tau immunoreactivity (Falangola et al., 2022).”
From Multimodal MRI combined with RNA sequencing reveals pathological signatures in the 9-month-old 3×Tg-AD mouse brain (2026) · cites this paper as Falangola et al., 2022
The Results and Discussion (page unavailable) link diffusion-MRI changes in older 3xTg-AD mice to Aβ and tau pathology, and report Aβ and tau immunoreactivity. But the paper describes extracellular Aβ plaques and intracellular tau in 15-month-old mice; it does not characterize this stage by extensive intracellular Aβ aggregates or emerging extracellular Aβ and tau immunoreactivity. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
False-discovery-rate citation points to an ImageJ paper
MinorThe methods cite [25] for the Benjamini-Hochberg method, but reference 25 is an ImageJ paper; the Benjamini and Yosef false-discovery-rate paper is listed as reference 27.
“The Benjamini-Hochberg false discovery rate (FDR) method [25] was used to adjust for multiple testing”
“25. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis.”
Mouse-atlas citation points to a diffusion MRI paper
MinorThe cited reference [24] is titled as a study of diffusion tensor estimation, not a mouse atlas. The reference list identifies a mouse brain atlas as reference 26.
“Delineation of ROIs was guided by comparison of anatomical structures in the MRI slices with a standard mouse atlas [24]”
“24. Veraart J, Poot DH, Van Hecke W, Blockx I, Van der Linden A, Verhoye M, More accurate estimation of diffusion tensor parameters using diffusion Kurtosis imaging.”
Age-related increase claimed despite no age-dependent assessment
MinorThe discussion says Aβ plaque and tau pathology increased significantly with age, but the statistical methods say age-dependent changes were not assessed.
“Aβ plaque and tau pathology are evident in 15-month-old TG mice, and significantly increased with age (online supplementary Fig.1 and 2).”
“Due to the small number of mice at each time point, mice from all time points and from both groups, were pooled for statistical analysis, and age dependent changes were not assessed.”
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · see citing works
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works
The rician distribution of noisy mri data
Guðbjartsson, H., & Patz, S. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340618 · Cited by 2,498 · see citing works
Jensen, J. H., Helpern, J. A., Ramani, A., Lu, H., & Kaczynski, K. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20508 · Cited by 2,488 · see citing works
Self-citationDenoising of diffusion MRI using random matrix theory
Veraart, J., Novikov, D. S., Christiaens, D., Ades-aron, B., Sijbers, J., & Fieremans, E. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.016 · Cited by 1,905 · see citing works
MRI quantification of non-gaussian water diffusion by kurtosis analysis
Jensen, J. H., & Helpern, J. A. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1518 · Cited by 1,251 · see citing works
Self-citationAmyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · see citing works
Estimation of tensors and tensor‐derived measures in diffusional kurtosis imaging
Tabesh, A., Jensen, J. H., Ardekani, B. A., & Helpern, J. A. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22655 · Cited by 461 · see citing works
Self-citationNormal aging in the central nervous system: Quantitative MR diffusion-tensor analysis
Abe, O., Aoki, S., Hayashi, N., Yamada, H., Kunimatsu, A., Mori, H., Yoshikawa, T., Okubo, T., & Ohtomo, K. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00318-9 · Cited by 420 · see citing works
Lu, H., Jensen, J. H., Ramani, A., & Helpern, J. A. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1020 · Cited by 420 · see citing works
Self-citationClinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
Lam, B., Masellis, M., Freedman, M., Stuss, D. T., & Black, S. E. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt155 · Cited by 386 · see citing works
Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507892200 · Cited by 379 · see citing works
Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
Belfiore, R., Rodin, A., Ferreira, E., Velazquez, R., Branca, C., Caccamo, A., & Oddo, S. (2019) · Aging Cell · doi:10.1111/acel.12873 · Cited by 332 · see citing works
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model
Hirata-Fukae, C., Li, H.-F., Hoe, H.-S., Gray, A. J., Minami, S. S., Hamada, K., Niikura, T., Hua, F., Tsukagoshi-Nagai, H., Horikoshi-Sakuraba, Y., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.079 · Cited by 284 · see citing works
Carroll, J. C., Rosario, E. R., Kreimer, S., Villamagna, A., Gentzschein, E., Stanczyk, F. Z., & Pike, C. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.009 · Cited by 273 · see citing works
Desai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266 · see citing works
Diffusion tensor imaging in Alzheimer’s disease and mild cognitive impairment.
Stebbins, G. T., & Murphy, C. M. (2009) · Behavioural Neurology · doi:10.1155/2009/915041 · Cited by 245 · see citing works
More accurate estimation of diffusion tensor parameters using diffusion kurtosis imaging
Veraart, J., Poot, D. H. J., Hecke, W. V., Blockx, I., der Linden, A. V., Verhoye, M., & Sijbers, J. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22603 · Cited by 237 · see citing works
Desai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100087 · Cited by 232 · see citing works
Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Javonillo, D. I., Tran, K. M., Phan, J., Hingco, E., Kramár, E. A., da Cunha, C., Forner, S., Kawauchi, S., Milinkeviciute, G., Gomez-Arboledas, A., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.785276 · Cited by 203 · see citing works
Song, S.-K., Kim, J. H., Lin, S.-J., Brendza, R. P., & Holtzman, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.003 · Cited by 170 · see citing works
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166 · see citing works
Praet, J., Manyakov, N. V., Muchene, L., Mai, Z., Terzopoulos, V., de Backer, S., Torremans, A., Guns, P.-J., Van De Casteele, T., Bottelbergs, A., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0329-8 · Cited by 133 · see citing works
Sun, S.-W., Song, S.-K., Harms, M. P., Lin, S.-J., Holtzman, D. M., Merchant, K. M., & Kotyk, J. J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.09.006 · Cited by 121 · see citing works
Quantitative assessment of diffusional kurtosis anisotropy
Glenn, G. R., Helpern, J. A., Tabesh, A., & Jensen, J. H. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3271 · Cited by 113 · see citing works
Self-citationOh, K.-J., Perez, S. E., Lagalwar, S., Vana, L., Binder, L., & Mufson, E. J. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/780102 · Cited by 105 · see citing works
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
Perez, S. E., He, B., Muhammad, N., Oh, K.-J., Fahnestock, M., Ikonomovic, M. D., & Mufson, E. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.002 · Cited by 80 · see citing works
Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model
Zerbi, V., Kleinnijenhuis, M., Fang, X., Jansen, D., Veltien, A., Van Asten, J., Timmer, N., Dederen, P. J., Kiliaan, A. J., & Heerschap, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.017 · Cited by 74 · see citing works
Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease
Vanhoutte, G., Pereson, S., y Palacios, R. D., Guns, P., Asselbergh, B., Veraart, J., Sijbers, J., Verhoye, M., Broeckhoven, C. V., & der Linden, A. V. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24680 · Cited by 50 · see citing works
Manno, F. A. M., Isla, A. G., Manno, S. H. C., Ahmed, I., Cheng, S. H., Barrios, F. A., & Lau, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00039 · Cited by 49 · see citing works
Qin, Y.-Y., Li, M.-W., Zhang, S., Zhang, Y., Zhao, L.-Y., Lei, H., Oishi, K., & Zhu, W.-Z. (2013) · Neuroradiology · doi:10.1007/s00234-013-1195-0 · Cited by 42 · see citing works
Voxel-based diffusion tensor imaging of an APP/PS1 mouse model of Alzheimer’s disease.
Shu, X., Qin, Y.-Y., Zhang, S., Jiang, J.-J., Zhang, Y., Zhao, L.-Y., Shan, D., & Zhu, W.-Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8418-6 · Cited by 41 · see citing works
Snow, W. M., Dale, R., O’Brien-Moran, Z., Buist, R., Peirson, D., Martin, M., & Albensi, B. C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170136 · Cited by 29 · see citing works
Past to Future: What Animal Models Have Taught Us About Alzheimer’s Disease
Martini, A. C., Forner, S., Trujillo‐Estrada, L., Baglietto‐Vargas, D., & LaFerla, F. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179917 · Cited by 26 · see citing works
Falangola, M. F., Nie, X., Ward, R., Dhiman, S., Voltin, J., Nietert, P. J., & Jensen, J. H. (2021) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2021.06.022 · Cited by 25 · see citing works
Kastyak-Ibrahim, M. Z., Di Curzio, D. L., Buist, R., Herrera, S. L., Albensi, B. C., Del Bigio, M. R., & Martin, M. (2013) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2013.06.013 · Cited by 23 · see citing works
Diffusion MRI detects early brain microstructure abnormalities in 2-month-old 3×Tg-AD mice
Falangola, M. F., Nie, X., Ward, R., McKinnon, E. T., Dhiman, S., Nietert, P. J., Helpern, J. A., & Jensen, J. H. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4346 · Cited by 22 · see citing works
Self-citationNie, X., Falangola, M. F., Ward, R., McKinnon, E. T., Helpern, J. A., Nietert, P. J., & Jensen, J. H. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2018.12.003 · Cited by 22 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The 3xTg-AD Mouse Model: A Comprehensive Tool for Understanding Alzheimer’s Disease
Pattanayak, A., & Firdous, S. M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01655-w · Cited by 11 · see citing works
“Significant alterations in diffusion metrics were observed in the subiculum and hippocampal regions of older mice, which were associated with neuronal loss and damage (Falangola et al. 2022).”
Knopper, R. W., Skoven, C. S., Eskildsen, S. F., Østergaard, L., & Hansen, B. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1498133 · Cited by 7 · see citing works
Bergamino, M., Nelson, M. R., Numani, A., Scarpelli, M., Healey, D., Fuentes, A., Turner, G., & Stokes, A. M. (2023) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2023.03.024 · Cited by 4 · see citing works
Diffusion MRI in 2‐Month‐Old Mouse Brain Predicts Alzheimer's Pathology Genotype
Falangola, M. F., Granger, B., Voltin, J. R., Nietert, P. J., Berto, S., & Jensen, J. H. (2025) · NMR in Biomedicine · doi:10.1002/nbm.70018 · Cited by 4 · see citing works
Self-citationWang, Z., Li, H., Shi, B., Qin, Q., Ye, Q., & Thompson, G. J. (2025) · Network Neuroscience · doi:10.1162/netn.a.28 · Cited by 3 · see citing works
“…(DTI), to visualize the microstructure of neuron fiber in white matter (WM) and gray matter (GM) (Assaf & Pasternak, 2008; Filley & Fields, 2016; Zhang et al., 2012), including fractional anisotropy (FA) (Bergamino et al., 2023; Falangola et al., 2022, 2025; Manno et al., 2019; Snow et al., 2017).”
Yang, H. J., Tong, P., Dong, L., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.09.036 · Cited by 2 · see citing works
Li, Y., Tang, Z., Yao, M., Ran, Y., & Qiu, Z. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00006
“Combining neuroimaging techniques with RNA-seq methods can provide novel insights into the neurobiology of AD.”
- Authors
- Falangola, M. F., Nie, X., Voltin, J., Ward, R., Dhiman, S., Nietert, P. J., & Jensen, J. H.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Falangola, Maria Fatima
- Venue
- Magnetic Resonance Imaging
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 94
- Pages
- 48-55
- ISSN
- 0730-725X (ISSN-L)
- PMC
- PMC9695071
- OpenAlex
- W4296204199
- Semantic Scholar
- 6bafde7640f00dc5e030a20b01c02e85f964c322
- Cited by
- 6
- References
- 41
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 292 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Magnetic Resonance Imaging (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (1RF1AG057602–01)
- Medical University of South Carolina
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, 3xTg-AD mice, brain microstructure, diffusion MRI, diffusion kurtosis imaging, amyloid-beta pathology, tau pathology, hippocampus, fimbria, subiculum, fractional anisotropy, mean kurtosis, radial kurtosis, axial diffusivity, amyloid-beta 42, diffusion MRI biomarkers
- MeSH terms
- Correlation of Data, Aged, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Humans, Mice, Transgenic, Amyloid beta-Peptides, Diffusion Magnetic Resonance Imaging, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-24.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-24.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review